ARS Pharmaceuticals, Inc. (SPRY) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $327.65M | -6.7% |
| 2024 | $351.15M | +50.6% |
| 2023 | $233.19M | -17.1% |
| 2022 | $281.44M | +358.0% |
| 2021 | $61.45M | -84.4% |
| 2020 | $394.80M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $327.65M | -6.7% |
| 2024 | $351.15M | +50.6% |
| 2023 | $233.19M | -17.1% |
| 2022 | $281.44M | +358.0% |
| 2021 | $61.45M | -84.4% |
| 2020 | $394.80M | — |